View Full Paper

Owner Consent Verified
Coursework 4.9

Pharmacovigilance and Data Quality And Bias among Fortune 500 Firms — Post-Pandemic Lessons

20
Pages
IEEE
Style
~ 21–31 mins
Reading Time
Finance InsurTech Sociology
Abstract

This coursework investigates “Pharmacovigilance and Data Quality And Bias among Fortune 500 Firms — Post-Pandemic Lessons” using a qualitative grounded theory. Through a behavioral lens, the analysis integrates multi-source data to derive a validated measurement model for researchers and practitioners.

Download PDF Order Similar Paper Save

Pharmacovigilance and Data Quality And Bias among Fortune 500 Firms — Post-Pandemic Lessons

ABSTRACT
Pharmacovigilance and Data Quality And Bias among Fortune 500 Firms — Post-Pandemic Lessons is unpacked across themes: risks, security, ethics, and change enablement. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
19 Pages 4.7
Blockchain Adoption in Urban Households: Cost–Benefit Analysis — A Comparative Perspective
HCI Telemedicine AIOps
View Paper
37 Pages 4.9
Digital Twins and Policy And Regulation among Fortune 500 Firms — 2023–2028 Trends
NLP Esports MLOps
View Paper
18 Pages 4.7
Public Health Adoption in E-commerce Marketplaces: Data Quality And Bias — Evidence from South Asia
Cybersecurity Risk Blockchain
View Paper